...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Zenith AGM Corporation Update Slides and Webcast

Considering Zenith hasn't been around that long, I would say they are making lots of progress. Already doing Phase 2 with a Phase 3 trial soon. 

Share
New Message
Please login to post a reply